Hydrogen Studies at ClinicalTrials.gov
ABL in Am J Med Sci
A highly promising therapeutic, hydrogen appears to currently lack adequate effectiveness and safety evidence from well-controlled RCTs to meet the requirements of regulatory authorities to grant approval for clinical use. However, recent ten years have brought a notable upsurge in the number of clinical trials with hydrogen, thus suggesting a new compelling course in H2 appraisal. In the paper just published in The American Journal of the Medical Sciences, we enlisted all recent and ongoing clinical studies registered at ClinicalTrials.gov. From ischemic stroke to bronchiectasis to solid tumors, hydrogen is currently being evaluated in 12 trials from the US, China, and other countries, with ABL contributed significantly to this body of evidence.